WA SB5995 | 2017-2018 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on January 8 2018 - 25% progression, died in committee
Action: 2018-02-02 - Referred to Ways & Means.
Pending: Senate Ways & Means Committee
Text: Latest bill text (Comm Sub) [PDF]

Summary

Protecting consumers and purchasers from excessive increases in generic prescription drug prices.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Protecting consumers and purchasers from excessive increases in generic prescription drug prices.

Sponsors


History

DateChamberAction
2018-02-02SenateReferred to Ways & Means.
2018-02-01SenateMinority; without recommendation.
2018-02-01SenateAnd refer to Ways & Means.
2018-02-01SenateHLTC - Majority; 1st substitute bill be substituted, do pass.
2018-02-01SenateExecutive action taken in the Senate Committee on Health & Long Term Care at 10:00 AM.
2018-01-16SenatePublic hearing in the Senate Committee on Health & Long Term Care at 10:00 AM.
2018-01-08SenateFirst reading, referred to Health & Long Term Care.
2017-12-04SenatePrefiled for introduction.

Same As/Similar To

HB2556 (Crossfiled) 2018-01-10 - First reading, referred to Health Care & Wellness

Washington State Sources


Bill Comments

feedback